Elderly colon cancer patients are being given the chance to access a clinical trial led by the University of Leeds that could ...

Some insurers limit sessions to just 20 a year. They also often pause coverage to require re-authorization of physical ...

Up to 90% of colorectal cancers can be cured if caught early. Learn about screening options at Fred Hutch to protect your health.

The American Association for Cancer Research’s annual conference featured updates from several companies on key candidates ...

A new clinical trial shows the immunotherapy drug dostarlimab may eliminate the need for surgery and chemotherapy in certain ...

SafeHeal, a medical device company, received financing from investor Solar Eclipse, new investors Gideon Strategic Partners ...

At AACR 2025, researchers revealed that a liquid biopsy assay using ctDNA detected colorectal cancer recurrence months before ...

Almost 12% of patients with CRC are readmitted within 31 days after surgery, with certain demographic, surgical, and ...

New research suggests that a ctDNA assay can detect colorectal cancer recurrence months before it is detected via imaging.

Can ctDNA-guided therapy stop cancer’s return, sparing patients unnecessary treatment? A new study suggests it might.

In a continent where only 9pc of surgeons are women, these four trailblazers are rewriting the rules of operating theatres.

Neoadjuvant immunotherapy alone resulted in significant treatment response among most patients with mismatch-repair-deficient ...